Angiotensin converting enzyme inhibitors in heart failure: how good are they?

This publication has 22 references indexed in Scilit:

• Calcium antagonist caution
  The Lancet, 1991
• Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention
  International Journal of Cardiology, 1990
• Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
  The American Journal of Cardiology, 1987
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
  New England Journal of Medicine, 1986
• Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure
  Journal of the American College of Cardiology, 1985
• Captopril in heart failure. A double blind controlled trial.
  Heart, 1984
• Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
  Circulation, 1984
• Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
  Circulation, 1983
• Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placebo
  American Heart Journal, 1982
• Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol
  New England Journal of Medicine, 1981